Cargando…
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms
Autores principales: | Bueno, Maria J., Colomer, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721876/ https://www.ncbi.nlm.nih.gov/pubmed/28087115 http://dx.doi.org/10.1016/j.ebiom.2015.08.023 |
Ejemplares similares
-
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models
por: Polonio-Alcalá, Emma, et al.
Publicado: (2020) -
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
por: Puig, Teresa, et al.
Publicado: (2011) -
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
por: Crous-Masó, Joan, et al.
Publicado: (2018) -
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
por: Bueno, Maria J., et al.
Publicado: (2019) -
Repositioning Proton Pump
Inhibitors as Anticancer
Drugs by Targeting the Thioesterase Domain of Human Fatty Acid Synthase
por: Fako, Valerie E., et al.
Publicado: (2014)